共 23 条
[1]
Andersen L.W., Baek L., Degn H., Lehd J., Krasnuk M., Rasmussen J.P., Presence of circulating endotoxins during cardiac operations, J Thorac Cardiovasc Surg, 93, pp. 115-119, (1987)
[2]
Andersen L.W., Landow L., Baek L., Jansen E., Baker S., Association between gastric intramucosal pH and splanchnic endotoxin, and tumor necrosis factor-a concentrations in patients undergoing cardiopulmonary bypass, Crit Care Med, 21, 2, pp. 210-217, (1993)
[3]
Beattie H.W., Evans G., Garnett E.S., Webber C.E., Sustained hypovolemia and extracellular fluid volume expansion following cardiopulmonary bypass, Surgery, 71, 6, pp. 891-897, (1972)
[4]
Beattie H.W., Evans G., Garnett E.S., Regoezci E., Webber C.E., Wong K.-L., Albumin snd wutcr fluxus during curdiopul- monary bypass, J Thorac Cardiovasc Surg, 67, 6, pp. 926-931, (1974)
[5]
Butler J., Rocker G.M., Westaby S., Inflammatory response to cardiopulmonary bypass, Ann Thorac Surg, 55, pp. 552-559, (1993)
[6]
Chenoweth D.E., Cooper S.W., Hugli T.E., Stewart R.W., Black-Stone E.H., Kirklin J.W., Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins, N Engl J Med, 304, pp. 497-503, (1981)
[7]
D' Ambra M.N., Philbin D.M., Colloids should not be added to the pump prime, J Cardiothorac Vase Anest, 4, 3, pp. 406-408, (1990)
[8]
Deventer Van S., Biiller H.R., Cate Ten J.W., Aarden L.A., Hack C.E., Sturk A., Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways, Blood, 76, 12, pp. 2520-2526, (1990)
[9]
Downing S.W., Edmunds L.H., Release of vasoactive sub-stances during cardiopulmonary bypass, An Thorac Surg, 54, pp. 1236-1243, (1992)
[10]
Fiddian-Green R.G., Assessment of the adequacy of mucosal oxygenation in patients with intraluminally located silicone tonometers, Microcirculation in Circulatory Disorders, pp. 481-487, (1989)